DIT Life Sciences Trade mission to Japan and South Korea 2018

Explore new life sciences business opportunities by participating in a trade mission to Tokyo and Seoul, organised by the UK's Department for International Trade (DIT). The trade mission theme is Innovative Therapy & Drug Discovery and Development

DIT Life Sciences Trade mission to Japan and South Korea 2018

This trade mission is aimed at UK companies involved in the development of innovative therapy, innovative drug discovery and development platform and services such as:

  • Cell therapy
  • Gene therapy
  • RNA therapy
  • Innovative small molecule drug seeds
  • Microbiome
  • Tissue engineering
  • Cell culture, processing and quality evaluation
  • Innovative drug discovery and development technology platform and services
  • New DDS, etc

Japan Opportunities

Japan is the world’s second largest pharmaceutical market, after the US. It is also recognised as leading the world in the regenerative medicine regulations allowing early access of regenerative medicine and cell therapy products into the market, after Phase II conditional approval. Number of research-based Japanese pharmaceutical companies are actively looking to in-license innovative therapeutic pipelines for the Japanese market and also the state-of-art technologies and services for their drug discovery and development. Oncology is the main area of focus for many of pharmaceutical companies in Japan, but there are also opportunities in other therapeutic areas by more specialised pharma companies.

Korea Opportunities

Korea is the 13th largest pharmaceutical market. The biopharmaceutical industry is one of the fastest growing industries in Korea. Korea is the 8th strongest biotechnology nation with high technology and skills, especially in stem cells. Korea conducts more industry-sponsored drug studies than any other Asian countries. There are opportunities for R&D collaboration and technology transfers in the field of oncology, cardiology, drug discovery, metabolic diseases, vaccines, neuroscience, stem cells, cancer theranostics and tissue engineering & regenerative medicine etc. Korean companies are more willing to in-license than before, presenting new opportunities for UK companies.

Benefits of Attendance

  • Opportunity to give 10-15 minutes presentation at a mission seminar at the British Embassy in Tokyo (with simultaneous interpretation)
  • Opportunity to network with key contacts within Japanese pharmaceutical, biotech and life sciences companies at an after-seminar networking reception at the Embassy in Tokyo
  • Market briefing in Japan by a local regulatory consultant
  • Meet with DIT trade officers in Japan and South Korea to learn about the market opportunities and business cultures
  • Additional meeting arrangements outside of the trade mission seminar/networking reception with separate fees upon request

Join the DIT Trade Mission to Japan and South Korea to gain insight into opportunities in the 2 markets and expand your business potential and cultivate a network of contacts with Japanese and Korean pharmaceutical and life sciences companies.

Proposed Programme




Sunday 2 December

  • Arrive at Tokyo


Monday 3 December

  • Mission Briefing, Seminar and Networking Reception at British Embassy Tokyo      


Tuesday 4 December

  • Free for own arrangement in Tokyo / Osaka

Japan (Tokyo / Osaka)

Wednesday 5 December

  • Travel from Japan to South Korea OR
  • Free for own arrangement in Tokyo/Osaka

Japan (Tokyo / Osaka) / South Korea

Thursday 6 December

  • Meeting arrangements in South Korea OR
  • Free for own arrangement in Tokyo/Osaka

Japan (Tokyo / Osaka) / South Korea

Friday 7 December

  • Meeting arrangements in South Korea OR
  • Free for own arrangement in Tokyo/Osaka

Japan (Tokyo / Osaka)  / South Korea

Saturday 8 December

  • Depart for the UK



How to Attend

Please register your interest by completing the application form below. The DIT Life Sciences team will review and assess all applications and shortlist companies to attend the trade mission. Results will be communicated by Friday 19 October.

The deadline for expressing interest in this trade mission is Friday 5 October 2018.

Please complete the following form to register your interest in the trade mission Innovative Therapy & Drug Discovery and Development to Japan and South Korea 2018.

Mission dates: Monday 3 December - Friday 7 December 2018. 
Markets: Tokyo, Japan and Seoul, South Korea. UK Companies can choose to visit both or either markets. 
Participation fee for Japan: £660 per company (exc VAT). Optional meeting arrangement service is offered and will be provided with a fee under DIT's Overseas Market Introduction Service (OMIS). 
Participation fee for South Korea: there are no events planned in Seoul, any requests will be handled on a case by case basis. 

Click here to view the form properly in a new tab.  

Contact Details

Event Organiser
Department of International Trade (Japan)
Main Contact
DIT Japan Life Science Trade Team

Event Details

View by Timezone: UK Time | Japan Time
03 December 2018
03 December 2018
07 December 2018
07 December 2018
£660 exl VAT